Filing Flows › Clover Health Investments (CLOV) › Q3 2026 › vs Q2 2026
Clover Health Investments (CLOV) Q3 2026 vs Q2 2026 (quarter over quarter)
Clover Health Investments's revenue rose $16.1M (+2%) from $743M in Q2 2026 to $759M in Q3 2026. Operating margin 0.8% against 3.8% (-2.9 pts).
Clover Health Investments, Q3 2026: revenue $759M (+53% year over year), operating margin 0.8%, net earnings $6.4M, operating cash flow $70.4M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 0.8% | 3.8% | -2.9 pts |
| Net margin | 0.8% | 3.8% | -2.9 pts |
| Free cash flow margin | 9.2% | 3.3% | +5.9 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $759M | $743M | $16.1M | +2% |
| Operating profit | $6.4M | $28.0M | −$21.6M | -77% |
| Costs & expenses | $753M | $715M | $37.7M | +5% |
| Pre-tax earnings | $6.4M | $28.0M | −$21.6M | -77% |
| General & admin | $66.8M | $70.3M | −$3.5M | -5% |
| Other operating costs | $686M | $645M | $41.2M | +6% |
| Net earnings | $6.4M | $28.0M | −$21.6M | -77% |
| Share-based compensation | $8.0M | $9.1M | −$1.1M | -12% |
| Working capital & other | $55.9M | −$11.9M | $67.8M | — |
| Operating cash flow | $70.4M | $25.2M | $45.2M | +179% |
| Free cash flow (OCF − capex) | $69.5M | $24.5M | $45.0M | +184% |
| Capital expenditures | $898K | $682K | $216K | +32% |
Questions
How much did Clover Health Investments's revenue grow quarter over quarter in Q3 2026?
Clover Health Investments's revenue rose $16.1M (+2%) from $743M in Q2 2026 to $759M in Q3 2026. Operating margin 0.8% against 3.8% (-2.9 pts).